What is the best initial treatment in Parkinson's disease?

Affiliations

Comment

M E Sharp et al. J R Coll Physicians Edinb. 2014.

. 2014;44(4):291-2.

doi: 10.4997/JRCPE.2014.409.

¹ ME SHarp, Division of Movement Disorders, Deparment of Neurology, Columbia University Medical Center New York, NY 10032, USA. Email ms4567@columbia.edu.

No abstract available

Comment on

Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial.
PD Med Collaborative Group; Gray R, Ives N, Rick C, Patel S, Gray A, Jenkinson C, McIntosh E, Wheatley K, Williams A, Clarke CE. PD Med Collaborative Group, et al. Lancet. 2014 Sep 27;384(9949):1196-205. doi: 10.1016/S0140-6736(14)60683-8. Epub 2014 Jun 11. Lancet. 2014. PMID: 24928805 Clinical Trial.